Randal S. Weber, MD, FACS | Authors


Dr. Randal S. Weber on Anti-EGFR Agents Showing Efficacy in Squamous Cell Carcinoma

February 24, 2016

Weber says overactivity of these EGFR receptors may cause SCC tumors to become more aggressive. He adds that in a recent, small-scale study, effectively blocking the EGFR receptor in the tumor with anti-EGFR therapy proved to be successful.